Can a tropical tea shrink blood cancers?

NCT ID NCT07771803

First seen Aug 18, 2026 · Last updated Aug 18, 2026

Summary

This pilot study tests whether drinking tea made from soursop leaves can reduce the number of cancer cells in people with relapsed or refractory acute myeloid leukemia (AML) or multiple myeloma (MM) — blood cancers that have not responded to standard treatments. About 20 participants will drink increasing amounts of soursop tea over 21 days. The study will check for a drop in leukemia or myeloma markers and monitor for any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Soursop tea (dried leaves of Annona muricata)
What this could lead to
If soursop tea reduces cancer cells, it could offer a gentle, plant-based option for patients with AML or multiple myeloma who have run out of standard treatments.
What could go wrong
This is a very early, small pilot study. It may not show a clear benefit, and the tea could cause side effects. Results will need confirmation in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AML (ACUTE MYELOID LEUKEMIA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MDA at Cooper University Health Care

    RECRUITING

    Camden, New Jersey, 18103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.